期刊文献+

西布曲明对映体的毛细管电泳分离与定量分析方法研究 被引量:18

Chiral Separation and Quantitative Analysis of Sibutramine by Capillary Electrophoresis
下载PDF
导出
摘要 目的:采用毛细管电泳分离西布曲明手性异构体,建立准确、快速的定量分析西布曲明及其对映体的方法。方法:对运行缓冲液离子强度、pH、手性选择剂浓度、有机溶剂添加剂、毛细管内径进行了选择。电泳条件为:石英毛细管柱内径75μm,总长65.0 cm,有效长度51.6 cm;紫外检测波长223nm;分离电压18 kV;温度25℃;电动力进样,进样电压18 kV,进样时间3s。结果:在20 mmol·L-1β-环糊精、30 mmol·L-1磷酸盐、pH 5.40的运行缓冲液中,西布曲明对映体达到了基线分离。西布曲明在0.031-0.412 mg·mL-1浓度范围内,线性关系良好,两对映体的检测限分别为11 μg·mL-1和10 μg·mL-1。在制剂其它成分共存时西布曲明的回收率为96.9%,2种对映体的回收率分别为95.1%及98.7%。结论:在该条件下可以成功分离西布曲明对映体,并建立起西布曲明对映体定量分析的毛细管电泳方法。 Objectives: The enantiomeric separation of sibutramine by capillary electrophoresis using β-cyclodex trin as the chiral selector was studied. In order to determine sibutramine and its enantiomers,a quantitative method was set up. Methods: The effect of pH and concentration of electrophoretic running buffer, the concentration of β CD,organic additive and the internal diameter of the capillary on enantioseparation were investigated respectively. The separation was performed at 25℃ on a fused - silica capillary of 75 μm×65.0 cm, effective length 51.6 cm. The applied high voltage was 18 kV from anode to cathode and the detection wavelength was 223 nm. Samples were injected into the capillary by electrokinetic force at 18 kV for 3 seconds. Results:In the running buffer composed of 30 mmol·L-1 phosphate containing 20 mmol·L-1β- cyclodextrin, at pH 5. 40, the two enantiomers could be well separated. The linear concentration region of sibutramine was 0. 031-0. 412 mg·mL-1. The lowest detective concentration of two enantiomers were 11μg·mL-1 and 10 μg ?*** mL-1. The recoveries of sibutramine and two enantiomers with other constitutents in capsules were 96. 9% ,95. 1% and 98. 7% ,respectively. Conclusions: Under the optimal operation condition, the enantiomers of sibutramine were separated at baseline in the electropherogram. The quantitative analytical method of sibutramine and its enantiomers was set up.
出处 《药物分析杂志》 CAS CSCD 北大核心 2004年第2期113-116,共4页 Chinese Journal of Pharmaceutical Analysis
基金 国家自然科学基金(20175038) 教育部"高校青年教师奖"(教人司[2002]123)资助
关键词 西布曲明 手性拆分 毛细管电泳 Β-环糊精 定量分析 对映体 减肥药物 sibutramine,chiral separation,capillary electrophoresis, β-cyclodextrin(β-CD)
  • 相关文献

参考文献6

  • 1左晓春,笪宏远.新一代减肥药──西布曲明[J].中国临床药理学杂志,2000,16(2):155-157. 被引量:27
  • 2Yang JW. ( Sepracor Inc. ) Methods and composition for treating depression and other disorders using optically pure ( + ) sibutramine.PCT Int. Appl. WO 9400047 ( Cl. A51K31/45) ,06 Jan 1994,US Appl. 903034,23 Jun 1992 ;40pp.
  • 3Yang JW. ( Sepracor Inc. ) Pharnlaceutical compositions for treating depression and other cerebral disorders containing optically pure( - )sibutramine. PCT Int. Appl. WO 9400114( Cl. A61 K31/135 ) ,06 Jan1994, US Appl. 903040,23 Jun 1992 ;40pp.
  • 4Radhakrishna T, Narayana CL, Rao DS,et al. LC method for the determination of assay and purity of sibutramine hydrochlorlde and its enantiomers by chiral chromatography. J Pharm Biomed Anal ,2000,22 :627.
  • 5Lelievnre F, Gareil P. Selectivity in capillary electrophoresis : application to chiral separations with cyclodextrins. Anal Chem, 1997,69:385.
  • 6Wren SAC, Rowe RC. Theoretieal aspects of chiral separation in capillary electrophoresis Ⅱ. The role of organic solvent. J Chromatogr,1992,609:363.

二级参考文献10

  • 1Garratt CJ,Hind ID,Haddock RE.Single/repeat dose kinetics ofsibutramine metabolites in obeses subjects (abstract)[].Journal of Clinical Pharmacology.1995
  • 2Drouin P,Hanotin C,Courciers,et al.A dose-ranging study efficacy andtolerability of sibutramine in weight loss[].Int J Ohes.1994
  • 3Study number SB 1049,Federal Drug Administration New Drug Approvalpackge [on-line]. http://w.w.w.fda gov cder /foi /ida /index 97 htm . 1998
  • 4.Meridia (sibutramine hydrolride monohydrate)Product information knollpharmaceutical conpany[]..1997
  • 5Bach DS,Rissanen AM,Mendel CM et.al.Absence of cardiac valvedysfunction in obese patients treated with sibutrsmine[].International Journal of Obesity.1998
  • 6Silverstone T.Appetitie suppressants:a review[].Drugs.1992
  • 7Bray,G.A.,Ryan,D.H.,Gordon,D.A double-blind randomized placebo-controlled trial of sibutramine[].Obesity Research.1996
  • 8Garratt CJ,Hind ID,Haddock RE.Single/repeat dose kinetics ofsibutramine metabolites in obeses subjects(abstract)[].Journal of Clinical Pharmacology.1995
  • 9Luscombe GP,Hopcroft RH,Thomas PC,et al.The contribution ofmetabolites to the rapid and potent down-regulation of rat conical betaadrenoceptors by the putative antidepressant sibutramine hydrochloride[].Neuropharmacology.1989
  • 10Weintraub M.Rubio A,Golik A,et.al .Sibutramine in weight control: adose-ranging,efficacy study[].Clinical Pharmacology and Therapeutics.1991

共引文献26

同被引文献160

引证文献18

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部